New Phosphatidylserine Patent Could Take Ingredient Beyond Cognitive Support and into Sports
The patent describes the oral administration of PS to maintain healthy testosterone levels, especially in men experiencing decreased levels due to age, exercise, or hypogonadism
As a result of a partnership to study the role of phosphatidylserine (PS) to influence cortisol levels and help maintain healthy testosterone levels and promote healthy aging in exercising and non-exercising men, ingredients firm Chemi Nutra (White Bear Lake, MN) and consultant Increnovo (Milwaukee) have gained a new patent that could see PS’s usage expand beyond cognitive health and into sports nutrition.
The new patent, “Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels” (US Patent No. 8,124,594), describes the oral administration of PS to maintain healthy testosterone levels, especially in men experiencing decreased levels due to age, exercise, or hypogonadism (when sex glands decrease hormone production).
According to Scott Hagerman, president of Chemi Nutra, the new patent could also expand focus on PS as an ingredient for sports performance and bodily maintenance. “There has been a lot of research in recent years involving PS in the sports performance realm-looking at cortisol, stress and immune health, muscle soreness reduction and recovery, and improvements in weightlifting, running, and golf. This exciting new discovery will open additional doors for the use of PS in healthy aging, strength training, and body composition management, in men.”
“I am confident that PS will now move beyond its well-known cognitive enhancing health benefits and into this new area of use, as people become aware of these newest hormone related attributes,” he added.
“For the first time, it is now proven that short-term supplementation with a moderate dose of PS not only prevents a stress induced increase in cortisol concentrations, PS additionally can naturally benefit impaired testosterone levels,” added Dr. Martin Purpura, managing member of Increnovo. “These new findings, protected by this recently granted patent, will open new markets for Chemi Nutra’s branded PS, SerinAidPS, for PS-based antiaging and sports nutrition nutritional supplements.”
